51. Applicability of RPMI 2650 and Calu-3 cell models for evaluation of nasal formulationsNadica Sibinovska, Simon Žakelj, Jurij Trontelj, Katja Kristan, 2022, original scientific article Keywords: RPMI 2650 cell line, Calu-3 cell line, nasal drug formulations, nasal epithelium, drug permeability Full text (file, 689,95 KB) This document has more files! More... |
52. Polymorphisms in GNMT and DNMT3b are associated with methotrexate treatment outcome in plaque psoriasisJasna Grželj, Irena Mlinarič-Raščan, Pij B. Marko, Maruška Marovt, Tanja Gmeiner, Alenka Šmid, 2021, original scientific article Keywords: methotrexate, pharmacogenetics, psoriasis, methionine cycle, drug response, hepatotoxicity Full text (file, 2,77 MB) This document has more files! More... |
53. Incorporation of ethylcellulose microparticles containing a model drug with a bitter taste into nanofibrous mats by the electrospinning technique - preliminary studiesKatarzyna Olechno, Nina Katarina Grilc, Špela Zupančič, K. Winnicka, 2022, original scientific article Keywords: electrospinning, electrospun nanofibers, drug delivery platform, ethylcellulose, microparticles, rupatadine fumarate, orodispersible films Full text (file, 1,28 MB) This document has more files! More... |
54. Cell models for Alzheimer’s and Parkinson’s diseaseSandra Cetin, Damijan Knez, Stanislav Gobec, Janko Kos, Anja Pišlar, 2022, review article Keywords: neurodegenerative diseases, cell models, cytotoxicity assays, drug discovery, drug screening Full text (file, 1,65 MB) This document has more files! More... |
|
56. Pharmacokinetic-pharmacodynamic model of vedolizumab for targeting endoscopic remission in patients with Crohn diseaseJurij Hanžel, Erwin Dressen, Séverine Vermeire, Mark Löwenberg, Frank Hoentjen, Peter Bossuyt, Esmé Clasquin, Filip J. Baert, Geert R. D'Haens, Ron Mathôt, 2022, original scientific article Keywords: therapeutic drug monitoring, exposure-response, pharmacometrics, inflammatory bowel disease, Crohn's disease, drug clearance, endoscopy, pharmacodynamics, infusion procedures, disease remission, vedolizumab, therapy Full text (file, 2,05 MB) This document has more files! More... |
57. Catalytic stereoconvergent synthesis of homochiral β‑CF$_3$, β‑SCF$_3$, and β‑OCF$_3$ benzylic alcoholsAndrej Emanuel Cotman, Pavel A. Dub, Maša Sterle, Matic Lozinšek, Jaka Dernovšek, Živa Zajec, Anamarija Zega, Tihomir Tomašič, Dominique Cahard, 2022, original scientific article Keywords: adaptive crystals, asymmetric catalysis, density functional calculations, drug design, fluorine, hydrogenation, kinetic resolution, ruthenium, alcohols, catalysts, crystals, ketones, stereoselectivity Full text (file, 2,08 MB) This document has more files! More... |
58. Discovery of a fragment hit compound targeting D-Ala:D-Ala ligase of bacterial peptidoglycan biosynthesisMatic Proj, Martina Hrast, Gregor Bajc, Rok Frlan, Anže Meden, Matej Butala, Stanislav Gobec, 2023, original scientific article Keywords: fragment-based drug discovery, hit triage, inhibitors, antibacterial agents Full text (file, 1,79 MB) This document has more files! More... |
|
60. Potential Drug-Drug Interactions among Patients with Schizophrenia Spectrum DisordersCvetka Bačar, Katja Nagode, Mitja Pišlar, Aleš Mrhar, Iztok Grabnar, Tomaž Vovk, 2023, original scientific article Keywords: potential drug—drug interactions, schizophrenia, antipsychotics, drug interaction program, symptoms and signs, risk factors Full text (file, 941,45 KB) This document has more files! More... |